Lazar David E. Insider Trading Activity (ATER)

Summary

Updated Jul 16, 2026

Lazar David E. has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $50K. Lifetime open-market sales: $83K.

Profile

David E. Lazar is a corporate executive known for his roles in various biopharmaceutical companies, including serving as President and CEO of Kala Bio Inc. He has also held significant positions in companies such as LQR House Inc. and NovaBay Pharmaceuticals.

Role	Director
Notability	30/100

Board memberships

Kala Bio Inc.
LQR House Inc.
NovaBay Pharmaceuticals, Inc.
Bio Green Med Solution, Inc.
MINIM, INC.

Awards & honors

Leadership in biopharmaceutical development
CEO of multiple companies
Director roles in various firms

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-04-02	SOWG	Sow Good Inc.	A — Grant or award	5.74M	$0.14	$820K
2026-01-30	SDEV	Stablecoin Development Corp	A — Grant or award	6.39M	—
2025-07-30	BGMS	Bio Green Med Solution, Inc.	S — Open-market sale	6.8K	$12.36	$83K
2024-12-31	FIEE	MINIM, INC.	P — Open-market purchase	1.46M	$0.03	$50K
2024-11-25	LQR	LQR House Inc.	S — Open-market sale	280.0K	—
2024-11-25	LQR	LQR House Inc.	S — Open-market sale	821.8K	—

Frequently Asked Questions

Who is Lazar David E.?

How many SEC Form 4 filings has Lazar David E. submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Lazar David E. been buying or selling stock?

Recorded transactions: 1 open-market purchases ($50K) and 6 open-market sales ($83K) across all tracked filings.

Where can I see all of Lazar David E.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Lazar David E. — SEC Form 4 Insider Trading Activity